Oklo Just Hit $75. Is $80 a Share Next? — Positive

OKLO   24/7 Wall Street — July 24, 2025

With a volume spike to 27 million shares, as compared to its daily average volume of 20.4 million, the OKLO stock is up about 12% to $75 a share.

image for news Oklo Just Hit $75. Is $80 a Share Next?

PayPal Now Available Directly in Wix Payments Platform in US — Positive

PYPL  WIX   PYMNTS — July 24, 2025

Wix and PayPal began rolling out a deeper integration that makes PayPal available directly in the Wix Payments platform.

image for news PayPal Now Available Directly in Wix Payments Platform in US

WEX Inc. (WEX) Q2 2025 Earnings Call Transcript — Neutral

WEX   Seeking Alpha — July 24, 2025

WEX Inc. (NYSE:WEX ) Q2 2025 Earnings Conference Call July 24, 2025 10:00 AM ET Company Participants Jagtar Narula - Chief Financial Officer Melissa D. Smith - Chairman of the Board, President & CEO Steven Alan Elder - Senior Vice President of Global Investor Relations Conference Call Participants Andrew William Jeffrey - William Blair & Company L.L.C.

image for news WEX Inc. (WEX) Q2 2025 Earnings Call Transcript

Elevance Health: CEO Buys As CareBridge Drives Strong Growth — Positive

ELV   Seeking Alpha — July 24, 2025

On July 18, the CEO bought $2.4MM worth, after the sell-off following the last earnings call. Carelon Services is growing fast, supported by the December acquisition of CareBridge. The aging population, the rising interest in well-being, and the potential expansion in Florida and Texas are a ray of light in the current gloomy context of the company.

image for news Elevance Health: CEO Buys As CareBridge Drives Strong Growth

Rollins, Inc. (ROL) Q2 2025 Earnings Call Transcript — Neutral

ROL   Seeking Alpha — July 24, 2025

Rollins, Inc. (NYSE:ROL ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants s - Corporate Participant Jerry E. Gahlhoff - Principal Executive Officer, President, CEO & Director Kenneth D.

image for news Rollins, Inc. (ROL) Q2 2025 Earnings Call Transcript

Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat? — Positive

RVTY   Zacks Investment Research — July 24, 2025

RVTY is likely to see another earnings beat as Diagnostics momentum and Signals Software growth offset tariff headwinds.

image for news Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?

Ameriprise Q2 Earnings Beat on Higher Revenues & AUM Growth — Positive

AMP   Zacks Investment Research — July 24, 2025

AMP beats Q2 earnings estimates as revenues climb 4% and AUM/AUA hit a record $1.58 trillion.

image for news Ameriprise Q2 Earnings Beat on Higher Revenues & AUM Growth

NEWTON, Kan., July 24, 2025 (GLOBE NEWSWIRE) -- Park Aerospace Corp. (NYSE-PKE) announced the retirement of Dale E. Blanchfield from the Company's Board of Directors. Mr. Blanchfield served on Park's board since 2004. He also served as the Company's Lead Independent Director since 2012.

image for news Park Aerospace Corp. Announces the Retirement of Dale E. Blanchfield From the Company's Board of Directors

OTIS' Q2 earnings miss and revised 2025 outlook triggered a steep sell-off, with persistent headwinds, especially in China and New Equipment segment. Despite near-term volatility from tariffs and weak demand, OTIS' Uplift and China transformation programs should drive cost savings and future profitability. Dividend remains well-covered and buybacks continue, supporting shareholder returns even as free cash flow expectations are lowered.

image for news Otis Worldwide: Headwinds Result In New 52-Week Low. Is Price Decline A Buying Opportunity?

Morning Brief anchor Julie Hyman breaks down the latest market news for July 24, 2025. Tesla shares are falling after issuing a disappointing Q2 report.

image for news Tesla stock sinks following Q2 earnings, Trump warns of 15 to 50% tariffs

SEI Investments Q2 Earnings Beat Estimates as Revenues & AUM Rise Y/Y — Positive

SEIC   Zacks Investment Research — July 24, 2025

SEIC posts a 70% y/y EPS surge and strong AUM growth in Q2, offset slightly by rising expenses and a revenue miss.

image for news SEI Investments Q2 Earnings Beat Estimates as Revenues & AUM Rise Y/Y

UDR Set to Report Q2 Earnings: What to Expect From the Stock? — Neutral

UDR   Zacks Investment Research — July 24, 2025

UDR readies to report Q2 earnings, with modest revenue growth expected, but FFO per share is likely to have remained flat year over year.

image for news UDR Set to Report Q2 Earnings: What to Expect From the Stock?

Celsius vs. PepsiCo: Which Beverage Stock Packs More Growth Ahead? — Positive

CELH  PEP   Zacks Investment Research — July 24, 2025

Celsius Holdings, Inc. CELH and PepsiCo, Inc. PEP are two influential players in the beverage industry. While PepsiCo stands as a diversified multinational powerhouse with a vast portfolio spanning sodas, snacks and hydration products, Celsius Holdings is a fast-growing disruptor focused on functional, sugar-free energy drinks marketed to health-conscious consumers.

image for news Celsius vs. PepsiCo: Which Beverage Stock Packs More Growth Ahead?

Pre-Markets Mixed Despite Strong Earnings Results — Positive

AAL  HON  UNH  UNP   Zacks Investment Research — July 24, 2025

Pre-Markets Mixed Despite Strong Earnings Results.

image for news Pre-Markets Mixed Despite Strong Earnings Results

Transaction in Own Shares — Neutral

SHEL   GlobeNewsWire — July 24, 2025

Transaction in Own Shares 24 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 24 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 24/07/2025 634,412 £26.8300 £26.4350 £26.6632 LSE GBP 24/07/2025 160,829 £26.8250 £26.4500 £26.6780 Chi-X (CXE) GBP 24/07/2025 86,759 £26.8300 £26.4500 £26.6534 BATS (BXE) GBP 24/07/2025 526,945 €31.0750 €30.6000 …

image for news Transaction in Own Shares

CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? — Positive

CRMD   Zacks Investment Research — July 24, 2025

CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

image for news CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock?

CoreWeave Bets Big on AI: Can Soaring Debt Pose a Financial Risk? — Positive

CRWV   Zacks Investment Research — July 24, 2025

CRWV's Q1 revenues surge 420% on AI demand, but rising debt and heavy capex raise questions about sustainability.

image for news CoreWeave Bets Big on AI: Can Soaring Debt Pose a Financial Risk?

PCEF: Still A Sell On A Relative Value Basis — Neutral

PCEF   Seeking Alpha — July 24, 2025

PCEF is a passive fund-of-funds ETF, mainly extracting dividends from closed-end funds. While PCEF offers decent long-term returns and yield, it lacks the active management needed to exploit CEF market inefficiencies. CEFS, an actively managed competitor, has significantly outperformed PCEF by leveraging activist strategies and capitalizing on CEF discounts.

image for news PCEF: Still A Sell On A Relative Value Basis

BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains? — Positive

BHST   Zacks Investment Research — July 24, 2025

BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

image for news BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?

CSX Q2 Earnings Came Ahead of Estimates, Revenues Decline Y/Y — Negative

CSX   Zacks Investment Research — July 24, 2025

CSX's second-quarter 2025 revenues are hurt by lower export coal prices, reduced fuel surcharge, and a decline in merchandise volume.

image for news CSX Q2 Earnings Came Ahead of Estimates, Revenues Decline Y/Y